We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| DMG Mori AG | AQEU:GILD | Aquis Europe | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.10 | -0.23% | 43.40 | 43.30 | 44.10 | 43.40 | 43.40 | 43.40 | 2 | 16:29:00 |
From Jun 2019 to Jun 2024
Cipla Ltd. (500087.BY) said Tuesday it has secured tentative approval from the U.S. Food and Drug Administration for tenofovir disoproxil fumarate, used to treat HIV.
It has received tentative approval to sell the drug in tablet form in dosages of 300 milligram under the President's Emergency Plan for AIDS Relief program, the Indian drugmaker said in a note to the Bombay Stock Exchange.
Tenofovir disoproxil fumarate tablets are the generic version of Gilead Sciences Inc.'s (GILD) truvada.
-By Satish Sarangarajan; Dow Jones Newswires; +91 22 6145 6120; satish.sarangarajan@dowjones.com
1 Year DMG Mori Chart |
1 Month DMG Mori Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
